SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Oxford Biomedica: PDMR Peter Soelkner buys 1,672.27 shares

Non-Executive Director and Vice Chair Peter Soelkner bought 1,672.27 ordinary shares on 28 September 2026 at EUR 5.959 each. He now holds 3,338.94 shares, equal to 0.00275% of the company.

OXB.L